4. Marketing the Site for Trial Opportunities
ā¢ CenterWatch www.centerwatch.com
ā¢ Clinical Investigators Directory online
www.clinicalinvestigators.com
ā¢ Pharma company websites
ā¢ Networking, word of mouth, previous
experience
5. Study/Investigator Match
ā¢ Notification of study opportunity by
sponsor
ā¢ Database of potential Investigators to
match with opportunities
ā¢ Physician or staff contact with research
office, protocol in hand
6. Project Setup Procedure
ā¢ Can be standardized for most projects
ā¢ Early feasibility determinations made
ā¢ Assures minimum time and effort spent on
an infeasible project
7. Feasibility after Receiving Full Protocol
ā¢ First team feasibility assessment
ā¢ Can more accurately determine potential
subject population
ā¢ Pharmacy issues
ā¢ Logistical issues of facilities, manpower
8. Site Evaluation Visit
ā¢ Receive letter from CRA outlining
requirements
ā¢ Schedule time with all affected study site
personnel
ā¢ Host the visit by accompanying the CRA
9. Team Meeting
ā¢ After receiving full protocol
ā¢ Include all affected parties
ā¢ Use draft budget and meeting agenda as
discussion tools
10. Study Budget
ā¢ Internal budget of actual costs and indirect
costs
ā¢ Tool for project management
ā¢ Justification to sponsor of requested amounts
during negotiation
ā¢ Use for planning and fund allocation
throughout project
11. Budget Development and
Negotiation
ā¢ Standard startup costs and hourly rates for
Study Coordinator time
ā¢ Draft budget modified per type of protocol,
discussions
ā¢ Use budget for negotiation with sponsor
12. Payment Schedule
ā¢ Part of Clinical Trial Agreement
ā¢ Startup payments, non-refundable
ā¢ Pro-rated payments during project
correspond to effort
ā¢ Have good cash flow during project
14. Project Implementation Phase
ā¢ Feasibility has been determined
ā¢ Continue with contract review, IRB and
regulatory submissions, and clinical setup
simultaneously
15. Contract Review
ā¢ Draft contract provided by sponsor
ā¢ Budget is part of contract
ā¢ Use templates for standard language
16. Standard Contract Language
ā¢ Publication Restrictions, Intellectual
Property
ā¢ Indemnification
ā¢ Confidential information and HIPAA
17. IRB/Regulatory Submissions
ā¢ Use local IRB
ā¢ Research Privacy Board
ā¢ Regulatory documents submitted to
Sponsor/CRO
ā¢ Copies of submissions kept in study files
18. Informed Consent Document
ā¢ 21 CFR 50 and 45 CFR 46
ā¢ Use lay language and appropriate reading
comprehension level
ā¢ Template usually provided by sponsor
19. IRB Review
ā¢ PI presents protocol to local IRB
ā¢ IRB issues a modification request letter
ā¢ Consent Form modifications are first approved
by the Sponsor
ā¢ IRB approval letter is issued
20. Regulatory Submissions
ā¢ FDA Form 1572
ā¢ Protocol signature page, financial
disclosures of investigators
ā¢ IRB member roster and OHRP assurance
ā¢ IRB and RPB approval letters
21. Clinical Setup
ā¢ Good Clinical Practice Guidelines
ā¢ Standard Operating Procedures
ā¢ Recruitment plan for study
ā¢ Site Initiation
22. Site Initiation
ā¢ Government mandate to study sponsor
ā¢ On-site initiation or Investigatorās Meeting
ā¢ CRFs and study procedures discussed in
detail
23. On-Going Study Coordinator Duties
ā¢ Subject screening, enrollment, scheduling,
and CRF completion
ā¢ Monitor visits
ā¢ IRB and AE submissions
ā¢ Regular meetings with PI
24. Study Close-out
ā¢ Close-out visit by monitor
ā¢ Return of supplies and study drug
ā¢ Inform the IRB of closure
ā¢ Final data completion and query resolution
25. Study Project Payments
ā¢ Startup fees upon contract execution
ā¢ Per-subject, per-visit payments at intervals
during project
ā¢ Some payments must be invoiced separately
ā¢ Final payment upon query resolution of all
data